Hologic (FRA:HO1) Change In Receivables: €58 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HO1 Hologic Inc FRA:HO1
57 GF Score
Price €65.00
GF Value €70.17
! 5 Warning Signs
View Full Analysis

What is Hologic Change In Receivables?

Hologic FRA:HO1 57 Change In Receivables is €58 Mil as of Dec. 2025. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 5 warning signs investors should review.

Hologic's change in receivables for the quarter that ended in Dec. 2025 was €15 Mil. It means Hologic's Accounts Receivable declined by €15 Mil from Sep. 2025 to Dec. 2025 .

Hologic's change in receivables for the fiscal year that ended in Sep. 2025 was €7 Mil. It means Hologic's Accounts Receivable declined by €7 Mil from Sep. 2024 to Sep. 2025 .

Hologic's Accounts Receivable for the quarter that ended in Dec. 2025 was €499 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hologic's Days Sales Outstanding for the three months ended in Dec. 2025 was 50.88.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hologic's liquidation value for the three months ended in Dec. 2025 was €-673 Mil.

Hologic  (FRA:HO1) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hologic's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=498.907/894.821*91
=50.88

2. In Ben Graham's calculation of liquidation value, Hologic's accounts receivable are only considered to be worth 75% of book value:

Hologic's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2019.454-3361.002+0.75 * 498.907+0.5 * 587.979
=-673

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hologic Change In Receivables Related Terms

Hologic Change In Receivables Historical Data

* Premium members only.

The historical data trend for Hologic's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hologic Change In Receivables Chart

Hologic Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.27 275.02 -1.41 36.94 6.65

Hologic Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.82 -3.42 42.14 3.92 15.37
FRA:HO1
57GF Score
Hologic Inc FRA:HO1
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hologic Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €58 Mil mean?
Hologic (FRA:HO1) has a Change In Receivables of €58 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hologic and its competitors.
Is Hologic's Change In Receivables too high?
Hologic's current Change In Receivables is €58 Mil. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's Change In Receivables compare to WST and COO?
Hologic's Change In Receivables of €58 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hologic and its competitors. Hologic's current Change In Receivables is €58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current Change In Receivables of €58 Mil. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current Change In Receivables is €58 Mil. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Hologic (FRA:HO1), the current Change In Receivables is €58 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hologic (FRA:HO1) Overvalued in 2026?

Based on GuruFocus' analysis, Hologic stock appears to be undervalued. The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.

Key valuation signals for FRA:HO1:

  • Change In Receivables: €58 Mil
  • GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hologic Business Description

Address 250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score

Get the complete analysis for FRA:HO1

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price
€70.17
GF Value